Janux Therapeutics Inc
NASDAQ:JANX
Income Statement
Earnings Waterfall
Janux Therapeutics Inc
Revenue
|
8.1m
USD
|
Operating Expenses
|
-81.1m
USD
|
Operating Income
|
-73m
USD
|
Other Expenses
|
14.7m
USD
|
Net Income
|
-58.3m
USD
|
Income Statement
Janux Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
1
+126%
|
2
+135%
|
4
+80%
|
5
+33%
|
7
+39%
|
7
+10%
|
9
+17%
|
9
+5%
|
8
-14%
|
8
+9%
|
8
-5%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(5)
|
(7)
|
(12)
|
(23)
|
(37)
|
(49)
|
(62)
|
(70)
|
(76)
|
(83)
|
(85)
|
(84)
|
(81)
|
|
Selling, General & Administrative |
(2)
|
(2)
|
(4)
|
(7)
|
(10)
|
(15)
|
(18)
|
(21)
|
(22)
|
(24)
|
(25)
|
(25)
|
(26)
|
|
Research & Development |
(3)
|
(4)
|
(8)
|
(16)
|
(26)
|
(35)
|
(44)
|
(49)
|
(53)
|
(59)
|
(60)
|
(58)
|
(55)
|
|
Operating Income |
(5)
N/A
|
(6)
-30%
|
(11)
-81%
|
(21)
-84%
|
(33)
-56%
|
(44)
-34%
|
(55)
-25%
|
(62)
-13%
|
(67)
-8%
|
(74)
-10%
|
(77)
-5%
|
(75)
+3%
|
(73)
+3%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(2)
|
(1)
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
7
|
10
|
13
|
15
|
|
Pre-Tax Income |
(7)
N/A
|
(8)
-13%
|
(11)
-49%
|
(21)
-83%
|
(33)
-56%
|
(44)
-34%
|
(54)
-24%
|
(60)
-11%
|
(63)
-4%
|
(67)
-6%
|
(68)
-1%
|
(63)
+8%
|
(58)
+7%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(7)
|
(8)
|
(11)
|
(21)
|
(33)
|
(44)
|
(54)
|
(60)
|
(63)
|
(67)
|
(68)
|
(63)
|
(58)
|
|
Net Income (Common) |
(7)
N/A
|
(8)
-13%
|
(11)
-49%
|
(21)
-83%
|
(33)
-56%
|
(44)
-34%
|
(54)
-24%
|
(60)
-11%
|
(63)
-4%
|
(67)
-6%
|
(68)
-1%
|
(63)
+8%
|
(58)
+7%
|
|
EPS (Diluted) |
-0.17
N/A
|
-0.19
-12%
|
-0.28
-47%
|
-0.51
-82%
|
-0.78
-53%
|
-1.05
-35%
|
-1.31
-25%
|
-1.45
-11%
|
-1.52
-5%
|
-1.62
-7%
|
-1.63
-1%
|
-1.36
+17%
|
-1.32
+3%
|